Cited by

• Predictors and outcomes of heart failure with mid-range ejection fraction.

  Bhambhani V, Kizer JR, Lima JAC, van der Harst P, Bahrami H, Nayor M, de Filippi CR, Enserro D, Blaha MJ, Cushman M, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Brouwers FP, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL Jr, Levy D, Herrington DM, van Gilst WH, Bertoni AG, Larson MG, de Boer RA, Gottdiener JS, Shah SJ, Ho JE. Bhambhani V, et al. Eur J Heart Fail. 2018 Apr;20(4):651-659. doi: 10.1002/ejhf.1091. Epub 2017 Dec 11. Eur J Heart Fail. 2018. PMID: 29226491 Free PMC article.
• Heart Failure Mid-Range Ejection Fraction.

  Martinez PF, Okoshi MP, Okoshi K, Oliveira-Junior SA. Martinez PF, et al. Arq Bras Cardiol. 2021 Jan;116(1):24-25. doi: 10.36660/abc.20200576. Arq Bras Cardiol. 2021. PMID: 33566961 Free PMC article. English, Portuguese. No abstract available.
• Sacubitril/Valsartan vs ACE Inhibitors or ARBs: A Systematic Review and Meta-Analysis of Randomized Trials.

  Evbayekha E, Idowu AB, LaRue S. Evbayekha E, et al. JACC Adv. 2025 Mar;4(3):101598. doi: 10.1016/j.jacadv.2025.101598. Epub 2025 Feb 18. JACC Adv. 2025. PMID: 39970741 Free PMC article.
• Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies.

  Unkovic P, Basuray A. Unkovic P, et al. Curr Treat Options Cardiovasc Med. 2018 Apr 3;20(4):35. doi: 10.1007/s11936-018-0628-9. Curr Treat Options Cardiovasc Med. 2018. PMID: 29616374 Review.
• Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction.

  van Woerden G, van Veldhuisen DJ, Manintveld OC, van Empel VPM, Willems TP, de Boer RA, Rienstra M, Westenbrink BD, Gorter TM. van Woerden G, et al. Circ Heart Fail. 2022 Mar;15(3):e009238. doi: 10.1161/CIRCHEARTFAILURE.121.009238. Epub 2021 Dec 22. Circ Heart Fail. 2022. PMID: 34935412 Free PMC article.